Tioguanine Active Not Recruiting Phase 3 Trials for Childhood B Lymphoblastic Lymphoma / Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 / B-cell Childhood Acute Lymphoblastic Leukemia / Acute Lymphoblastic Leukemia (ALL) / Philadelphia Chromosome Positive (Ph+) / Hypodiploid B Acute Lymphoblastic Leukemia / Ann Arbor Stage II B Lymphoblastic Lymphoma / Ann Arbor Stage I B Lymphoblastic Lymphoma / Down Syndrome (DS) / Adult B Lymphoblastic Lymphoma Treatment

Back to Tioguanine
IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01190930
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma